Skip to Main

Search

Results 701 to 710 of 935 for ""

New frontiers in neuroscience: 10 years of progress at UTSW’s O’Donnell Brain Institute: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-obi-10-year-anniversary.html

In her new office at UT Southwestern Medical Center, Ceci Verbaarschot, Ph.D., sits among unpacked boxes and discusses the intricacies of a brain-computer interface she is developing. The device is designed to restore sensation and movement in the upper limbs of people who are paralyzed from the

Aspirin use best for those with high coronary calcium, low risk of bleeding : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/aspirin-use-best-for-those-with-high-coronary-calcium.html

An X-ray test commonly used to assess hardening of the arteries could help doctors decide whether the benefits of taking aspirin to prevent a first heart attack or stroke outweigh the risks of bleeding from its use, UT Southwestern research suggests.

Home-time metric needed to judge hospital readmissions, studies suggest : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/home-time-metric-needed-to-judge-hospital-readmissions.html

Two new studies suggest Medicare’s system of penalizing hospitals if too many patients are readmitted within 30 days should also look at whether the patients were well enough to remain in their home during that time.

UT Southwestern leads national efforts around childhood blood disorders : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/ut-southwestern-leads-national-efforts.html

Studies highlight how collaborative research can improve the diagnosis and treatment of childhood blood disorders such as aplastic anemia and MDS

Revised clinical trial rules during COVID-19 pandemic may benefit patients, survey shows: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/revised-clinical-trial-rules-during-covid-19.html

The COVID-19 pandemic has led to new rules and expectations for clinical trials.

UTSW scientists identify mechanism crucial for COVID-19 virus replication: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/august-covid-19-virus-replication.html

A team led by UT Southwestern researchers has identified how SARS-CoV-2, the virus that causes COVID-19, builds a structure called the RNA cap that’s critical for successful viral replication.

Study reveals molecular ‘switch’ that turns on inflammation in obesity: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-molecular-switch-inflammation-obesity.html

A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread inflammation, providing long-sought insight into why obesity increases the risk of Type 2 diabetes, cardiovascular disease, fatty liver disease, and certain cancers.

UT Southwestern biochemist Steven McKnight, Ph.D., earns Lasker Award

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-lasker.html

Steven McKnight, Ph.D., Professor of Biochemistry at UT Southwestern Medical Center, has been awarded the Albert Lasker Basic Medical Research Award.

UTSW named Specialized Program of Research Excellence for liver cancer

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-liver-cancer.html

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).

UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/jan-novel-treatment-rare-eye-cancer.html

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.